uniQure stock jumps as FDA accepts Huntington’s therapy filing

More in Health

• STAT+: FDA OKs generic HIV prevention shot, widening access for lower-income countries

  Dr. Reddy’s Laboratories has secured tentative regulatory clearance to manufacture a lower-cost alternative to Gilead Sciences' lenacapavir, backed by global health groups. The six-month injectable medicine delivers virtually complete protection against infection, making it a critical asset for international eradication initiatives. This move drastically lowers financial barriers by bringing the price of long-acting prophylaxis in line with existing daily oral regimens.

  1 min read
• Violence in northern Ethiopia pushing health system towards collapse: WHO

  Clashes and drone strikes involving government forces and Tigrayan rebels have shattered a 2022 peace agreement, leaving medical facilities starved of staff, medicine, and working equipment. The surge in hostilities has disrupted ambulance routes and blocked aid deliveries amid mounting civilian casualties across affected regions. Without safe passage for humanitarians, the country faces the widespread loss of essential emergency and maternal care.

  2 min read
• Andhra school chainsaw attack: Accused may lose right leg after police encounter

  Medical specialists in Anantapur are evaluating the need for an above-knee surgical procedure on the suspect following his capture in the Atmakur forest area. Severe vascular trauma and impaired circulation from gunshot wounds threaten tissue vitality, even as the patient remains in stable condition. Meanwhile, advanced surgical interventions continue in Bengaluru for one of the teenage victims injured in the Raptadu classroom assault.

  1 min read